FB
FibroBiologics, Inc. Common Stock (FBLG)
NASDAQ·Healthcare·Biotechnology
$1.36
-4.90%
Mkt Cap $3.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | — | — | — | -$1.44 | -$0.98 | +31.94% | — | — |
| Q4 2025 Oct 31, 2025 | — | — | — | -$0.10 | -$0.13 | -30.00% | — | — |
| Q3 2025 Jul 31, 2025 | — | — | — | -$0.11 | -$0.12 | -9.09% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.10 | -$0.09 | +10.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.10 | -$0.09 | +5.73% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.09 | -$0.09 | +0.00% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | — | -$0.27 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.34 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.05 | — | — | — |
| Q3 2022 Sep 29, 2022 | — | — | — | — | -$0.05 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.04 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.04 | — | — | — |